Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension

Mesenchymal stem cell (MSC) extracellular vesicles (EVs) have beneficial effects in preclinical bronchopulmonary dysplasia and pulmonary hypertension (BPD-PH) models. The optimal source, dosing, route, and duration of effects are however unknown. The objectives of this study were to (a) compare the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Mayank, Bellio, Michael A, Benny, Merline, Kulandavelu, Shathiyah, Chen, Pingping, Janjindamai, Chawisa, Han, Chenxu, Chang, Liming, Sterling, Shanique, Williams, Kevin, Damianos, Andreas, Batlahally, Sunil, Kelly, Kaitlyn, Aguilar-Caballero, Daniela, Zambrano, Ronald, Chen, Shaoyi, Huang, Jian, Wu, Shu, Hare, Joshua M, Schmidt, Augusto, Khan, Aisha, Young, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cell-Based Drug Development, Screening, and Toxicology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397655/
https://www.ncbi.nlm.nih.gov/pubmed/35758326
http://dx.doi.org/10.1093/stcltm/szac041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397655/
https://www.ncbi.nlm.nih.gov/pubmed/35758326
http://dx.doi.org/10.1093/stcltm/szac041

Ejemplares similares